Beyond Medical Technologies Inc.
DOCT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 350.10K | 353.60K | 381.30K | 380.70K | 403.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 350.10K | 353.60K | 381.30K | 380.70K | 403.60K |
| Operating Income | -350.10K | -353.60K | -381.30K | -380.70K | -403.60K |
| Income Before Tax | -274.90K | -277.70K | -360.50K | -408.90K | -436.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.27 | -0.28 | -0.36 | -0.41 | -0.44 |
| Earnings from Discontinued Operations | -18.60K | -17.00K | -28.20K | -31.70K | -142.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -293.50K | -294.80K | -388.80K | -440.70K | -578.50K |
| EBIT | -350.10K | -353.60K | -381.30K | -380.70K | -403.60K |
| EBITDA | -- | -- | -- | -- | -112.30K |
| EPS Basic | -0.04 | -0.04 | -0.05 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.04 | -0.04 | -0.05 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 31.66M | 31.66M | 31.66M | 31.66M | 31.66M |
| Average Diluted Shares Outstanding | 31.66M | 31.66M | 31.66M | 31.66M | 31.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
